NCT00271414View on ClinicalTrials.gov

A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 1999

Study Completion Date

March 31, 2001

Conditions
Chronic Pain
Interventions
DRUG

Duragesic® (fentanyl) Transdermal Therapeutic System (TTS)

All Listed Sponsors
lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

NCT00271414 - A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy | Biotech Hunter | Biotech Hunter